Surgery, chemotherapy including maintenance therapies, targeted therapies, radiotherapy and palliative care all have a role in the management of patients with lung cancer, depending on stage. Recent advances in non-small cell lung cancer (NSCLC) include the use of stereotactic radiotherapy for patients...
The ability to identify and target specific molecular pathways for the treatment of cancer, including lung cancer, has been the Holy Grail of researchers and clinicians for more than two decades now. Sadly, however, despite strong preclinical evidence from both in vitro assays and animal models, ...
Lung cancer is the leading cause of cancer-related mortality in both men and women throughout the world, accounting for more than a quarter of the deaths (27%) as per the cancer statistics report 2016 [1]. An estimated 2.2 million new lung cancer cases will be diagnosed in 2016 [1]. ...
Treatment of Small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Background Small cell lung cancer (SCLC) is a lethal disease for which there have been only small advances in diagnosis and ...
1) The Best Choice in the Management of Lung Cancer 肺癌治疗最佳选择 2) lung cancer/therapy 肺癌/治疗 3) lung cancer treatment 肺癌治疗 例句>> 4) the best choice 最佳选择 1. According to the pol itical and economic environments, this essay, which is based on the profound ana lysis of...
lung (LCNEC). Systemic treatments for these aggressive tumors have largely remained unchanged for years. With the advancement in genomic sequencing and identification of novel targetable pathways over the last decade, a myriad of therapeutic options have emerged, addressing unmet needs for this patient...
One of the most common symptoms for lung cancer patients, dyspnea, can seriously impact patients' quality of life. Alongside conventional disease-focused approaches in lung cancer treatment, notably surgery, chemotherapy, and radiation therapy, physicians and researchers alike are increasingly attending to...
Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing our understanding of the disease biology and mechanisms of tumour progression, and advancing early detection and multimodal care. The use of small molecule tyrosine ...
(bio-nanocarriers and nano-biodevices) for multifaceted applications in lung cancer along with a comparative assessment of the principal advantages and shortcomings has been briefed upon. In the clinical context, disease management comprises four (quadripartite) different aspects: prophylaxis/prevention, ...
The majority of lung cancer cases can be traced to smoking tobacco. Additionally, genetics are believed to confer some susceptibility. Early detection offers the best hope for long-term survival. The choice of management options-including surgery, chemotherapy, and radiotherapy-depends on the ...